COVID-19 Stroke Apical Lung Examination Study 2: a national prospective CTA biomarker study of the lung apices, in patients presenting with suspected acute stroke (COVID SALES 2)
Titel:
COVID-19 Stroke Apical Lung Examination Study 2: a national prospective CTA biomarker study of the lung apices, in patients presenting with suspected acute stroke (COVID SALES 2)
Auteur:
Ratneswaren, T. Chan, N. Aeron-Thomas, J. Sait, S. Adesalu, O. Alhawamdeh, M. Benger, M. Garnham, J. Dixon, L. Tona, F. McNamara, C. Taylor, E. Lobotesis, K. Lim, E. Goldberg, O. Asmar, N. Evbuomwan, O. Banerjee, S. Holm-Mercer, L. Senor, J. Tsitsiou, Y. Tantrige, P. Taha, A. Ballal, K. Mattar, A. Daadipour, A. Elfergani, K. Barker, R. Chakravartty, R. Murchison, A.G. Kemp, B.J. Simister, R. Davagnanam, I. Wong, O.Y. Werring, D. Banaras, A. Anjari, M. Mak, J.K.C. Falzon, A.M. Rodrigues, J.C.L. Thompson, C.A.S. Haines, I.R. Burnett, T.A. Zaher, R.E.Y. Reay, V.L. Banerjee, M. Sew Hee, C.S.L. Oo, A.P. Lo, A. Rogers, P. Hughes, T. Marin, A. Mukherjee, S. Jaber, H. Sanders, E. Owen, S. Bhandari, M. Sundayi, S. Bhagat, A. Elsakka, M. Hashmi, O.H. Lymbouris, M. Gurung-Koney, Y. Arshad, M. Hasan, I. Singh, N. Patel, V. Rahiminejad, M. Booth, T.C.